PL352547A1 - Drugs containing inhibitors of human kinase h-sgk - Google Patents
Drugs containing inhibitors of human kinase h-sgkInfo
- Publication number
- PL352547A1 PL352547A1 PL00352547A PL35254700A PL352547A1 PL 352547 A1 PL352547 A1 PL 352547A1 PL 00352547 A PL00352547 A PL 00352547A PL 35254700 A PL35254700 A PL 35254700A PL 352547 A1 PL352547 A1 PL 352547A1
- Authority
- PL
- Poland
- Prior art keywords
- sgk
- drugs containing
- human kinase
- containing inhibitors
- inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19917990A DE19917990A1 (en) | 1999-04-20 | 1999-04-20 | Medicament containing inhibitors of cell volume regulated human kinase h-sgk |
PCT/EP2000/003578 WO2000062781A1 (en) | 1999-04-20 | 2000-04-19 | Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk |
Publications (2)
Publication Number | Publication Date |
---|---|
PL352547A1 true PL352547A1 (en) | 2003-08-25 |
PL198427B1 PL198427B1 (en) | 2008-06-30 |
Family
ID=7905297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL352547A PL198427B1 (en) | 1999-04-20 | 2000-04-19 | Drugs containing inhibitors of human kinase h-sgk |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1171131A1 (en) |
JP (1) | JP2002542196A (en) |
KR (1) | KR100718900B1 (en) |
CN (1) | CN1351496A (en) |
AU (1) | AU779941B2 (en) |
BR (1) | BR0009914A (en) |
CA (1) | CA2369078A1 (en) |
CZ (1) | CZ20013778A3 (en) |
DE (1) | DE19917990A1 (en) |
HU (1) | HUP0200819A3 (en) |
MX (1) | MXPA01010588A (en) |
NO (1) | NO20015054L (en) |
PL (1) | PL198427B1 (en) |
RU (1) | RU2288718C9 (en) |
SK (1) | SK14972001A3 (en) |
UA (1) | UA79066C2 (en) |
WO (1) | WO2000062781A1 (en) |
ZA (1) | ZA200108610B (en) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10042137A1 (en) * | 2000-08-28 | 2002-03-14 | Florian Lang | sgk2 and sgk3 as diagnostic and therapeutic targets |
DE10113876A1 (en) * | 2001-03-21 | 2002-09-26 | Eberhard Karls Uni Medizinisch | Quantitative diagnosis of genetically related hypertension, by correlating blood pressure with overexpression or modification of human sgk family proteins |
WO2002087417A2 (en) * | 2001-04-27 | 2002-11-07 | Cold Spring Harbor Laboratory | Alleviation of the memory deficits and memory components of psychiatric dysfunctions by altering atypical pkm activity |
DE10149393A1 (en) * | 2001-09-28 | 2003-04-24 | Florian Lang | Detecting the expression of serum and glucocorticoid-dependent kinase-1 (sgk1), for diagnosing coagulative diseases, diabetes, tumors, diabetes and autoimmune diseases, comprises using an antibody against sgk1 |
DE10225844A1 (en) * | 2002-06-04 | 2003-12-18 | Lang Florian | sgk and nedd as diagnostic and therapeutic targets |
DE10305212A1 (en) * | 2003-02-07 | 2004-08-19 | Florian Prof. Dr.med. Lang | Use of the sgk gene family for the diagnosis and therapy of cataracts and glaucoma |
KR20110005747A (en) * | 2003-03-03 | 2011-01-18 | 플로리안 랑 | Sgk1 as diagnostic and therapeutic target |
WO2004084889A1 (en) * | 2003-03-28 | 2004-10-07 | Pfizer Inc. | Use of protein kinase c inhibitor for suppressing sustained slow postsynaptic excitation (sspe) of enteric neurons |
DE10346913A1 (en) | 2003-10-09 | 2005-05-04 | Merck Patent Gmbh | acylhydrazone |
WO2005084702A1 (en) * | 2004-03-02 | 2005-09-15 | Hokkaido Technology Licensing Office Co., Ltd. | Agent for preventing and treating organ fibrosis |
JP2007529423A (en) * | 2004-03-11 | 2007-10-25 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | Methods for modulating glutamate receptors for the treatment of neuropsychiatric disorders, including the use of modulators of serum and glucocorticoid-inducible kinases |
KR20070015149A (en) * | 2004-03-11 | 2007-02-01 | 메르크 파텐트 게엠베하 | Methods for interfering with fibrosis |
US20090136920A1 (en) * | 2004-04-30 | 2009-05-28 | Stefan Golz | Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase 1 (sgk1) |
WO2005118832A2 (en) * | 2004-06-01 | 2005-12-15 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase-like protein (sgkl) |
DE102004030987A1 (en) * | 2004-06-26 | 2006-01-12 | Merck Patent Gmbh | Ortho-substituted (3-hydroxyphenyl) -acetic acid benzylidene hydrazides |
MX2007001155A (en) * | 2004-07-29 | 2007-08-14 | Creabilis Therapeutics Spa | Methods, systems, and computer program products for providing presence gateway functionality in a telecommunications network. |
DE102005001053A1 (en) * | 2005-01-07 | 2006-07-20 | Merck Patent Gmbh | Square acid derivatives |
DE102005015255A1 (en) | 2005-04-04 | 2006-10-05 | Merck Patent Gmbh | New acylhydrazide compounds are signal transduction kinase inhibitor, useful for treating and/or preventing diseases, e.g. diabetes, adiposity, metabolic syndrome, cancer and tumor cells |
DE102005035742A1 (en) * | 2005-07-29 | 2007-02-01 | Merck Patent Gmbh | New cyclobut-3-ene-1,2-dione derivatives are kinase inhibitors useful for treating e.g. cancer, hypertension, diabetes, glaucoma and bacterial infections |
DE102005039541A1 (en) * | 2005-08-22 | 2007-03-22 | Merck Patent Gmbh | 3-oxo-indazol-square acid derivatives |
DE102007002717A1 (en) | 2007-01-18 | 2008-07-24 | Merck Patent Gmbh | Heterocyclic indazole derivatives |
DE102007022565A1 (en) | 2007-05-14 | 2008-11-20 | Merck Patent Gmbh | Heterocyclic indazole derivatives |
EP2014651A1 (en) * | 2007-07-12 | 2009-01-14 | Exonhit Therapeutics SA | Compounds and methods for modulating Rho GTPases |
DE102008010362A1 (en) * | 2008-02-18 | 2009-08-20 | Florian Prof. Dr. Lang | Sgk1 as a therapeutic and diagnostic target for viral diseases |
DE102008010363A1 (en) | 2008-02-18 | 2009-08-20 | Lang, Florian, Prof. Dr.med. | Sgk1 as a therapeutic and diagnostic target for carcinomatous diseases |
DE102008010361A1 (en) | 2008-02-18 | 2009-08-20 | Merck Patent Gmbh | sgk1 inhibitors for the prophylaxis and / or therapy of viral diseases and / or carcinomas |
DE102008029072A1 (en) * | 2008-06-10 | 2009-12-17 | Lang, Florian, Prof. Dr.med. | Substance, which inhibits serum and glucocorticoid dependent kinase 3, useful for the prophylaxis and/or treatment or diagnosis of age-related diseases e.g. arteriosclerosis, skin atrophy, myasthenia, infertility, stroke and kyphosis |
DE102008038221A1 (en) | 2008-08-18 | 2010-02-25 | Merck Patent Gmbh | 7-azaindole derivatives |
DE102008038222A1 (en) | 2008-08-18 | 2010-02-25 | Merck Patent Gmbh | Indazol-5-carboxylic acid derivatives |
DE102008038220A1 (en) | 2008-08-18 | 2010-02-25 | Merck Patent Gmbh | oxadiazole |
DE102008059133A1 (en) | 2008-11-26 | 2010-05-27 | Merck Patent Gmbh | Difluorophenyl diacylhydrazide derivatives |
WO2012064981A2 (en) * | 2010-11-10 | 2012-05-18 | National Jewish Health | Methods to test allergic conditions |
CN107875153A (en) * | 2017-11-16 | 2018-04-06 | 上海壹志医药科技有限公司 | The medicinal usage of Des-N-methylchelerythrine |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5373501A (en) * | 1976-12-11 | 1978-06-30 | Kitasato Inst | Novel antibiotics amm2282 and process for preparing same |
US5242397A (en) * | 1989-06-20 | 1993-09-07 | Cedars-Sinai Medical Center | Catheter device and method of use for intramural delivery of protein kinase C and tyrosine protein kinase inhibitors to prevent restenosis after balloon angioplasty |
US5137912A (en) * | 1991-01-28 | 1992-08-11 | National Science Council Of Republic Of China | Chelerythrine inhibits platelet aggregation--a potential anti-aggregation drug |
GB9325395D0 (en) * | 1993-12-11 | 1994-02-16 | Ciba Geigy Ag | Compositions |
US5874464A (en) * | 1995-01-13 | 1999-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Conformationally constrained diacylglycerol analogues |
WO1997007081A2 (en) * | 1995-08-11 | 1997-02-27 | Yale University | Glycosylated indolocarbazole synthesis |
HUP9901621A3 (en) * | 1996-05-30 | 2002-01-28 | Aventis Pharmaceuticals Inc Br | Protein kinase c inhibitory activity alkyloxyamino substituted fluorenone derivatives, use thereof, intermediates and preparation of the latters, pharmaceutical compositions containing these compounds |
EP0887081B1 (en) * | 1997-06-27 | 2003-04-23 | Smithkline Beecham Corporation | Human serum glucocorticoid regulated kinase, a target for chronic renal disease and diabetic nephropathy |
EP0889127A1 (en) * | 1997-07-01 | 1999-01-07 | Smithkline Beecham Corporation | Serine/threonine protein kinase (H-SGK2) |
CO4940430A1 (en) * | 1997-07-07 | 2000-07-24 | Novartis Ag | POLYCLIC COMPOUNDS CONTAINING HYDROGENATED STAUROSPORIN WITH CONVENIENT PHARMACOLOGICAL PROPERTIES AND AN INHIBITING EFFECT ON THE GROWTH OF TUMOR CELLS |
-
1999
- 1999-04-20 DE DE19917990A patent/DE19917990A1/en not_active Ceased
-
2000
- 2000-04-19 JP JP2000611917A patent/JP2002542196A/en active Pending
- 2000-04-19 CZ CZ20013778A patent/CZ20013778A3/en unknown
- 2000-04-19 HU HU0200819A patent/HUP0200819A3/en unknown
- 2000-04-19 CA CA002369078A patent/CA2369078A1/en not_active Abandoned
- 2000-04-19 WO PCT/EP2000/003578 patent/WO2000062781A1/en not_active Application Discontinuation
- 2000-04-19 UA UA2001117896A patent/UA79066C2/en unknown
- 2000-04-19 PL PL352547A patent/PL198427B1/en unknown
- 2000-04-19 SK SK1497-2001A patent/SK14972001A3/en unknown
- 2000-04-19 CN CN00807959A patent/CN1351496A/en active Pending
- 2000-04-19 MX MXPA01010588A patent/MXPA01010588A/en not_active Application Discontinuation
- 2000-04-19 BR BR0009914-7A patent/BR0009914A/en not_active Application Discontinuation
- 2000-04-19 AU AU42972/00A patent/AU779941B2/en not_active Ceased
- 2000-04-19 RU RU2001131351/15A patent/RU2288718C9/en not_active IP Right Cessation
- 2000-04-19 EP EP00922655A patent/EP1171131A1/en not_active Withdrawn
- 2000-04-19 KR KR1020017013336A patent/KR100718900B1/en not_active IP Right Cessation
-
2001
- 2001-10-17 NO NO20015054A patent/NO20015054L/en not_active Application Discontinuation
- 2001-10-19 ZA ZA200108610A patent/ZA200108610B/en unknown
Also Published As
Publication number | Publication date |
---|---|
NO20015054D0 (en) | 2001-10-17 |
PL198427B1 (en) | 2008-06-30 |
ZA200108610B (en) | 2002-01-02 |
UA79066C2 (en) | 2007-05-25 |
RU2288718C9 (en) | 2008-04-27 |
SK14972001A3 (en) | 2002-06-04 |
WO2000062781A1 (en) | 2000-10-26 |
JP2002542196A (en) | 2002-12-10 |
EP1171131A1 (en) | 2002-01-16 |
DE19917990A1 (en) | 2000-11-02 |
CZ20013778A3 (en) | 2002-06-12 |
CN1351496A (en) | 2002-05-29 |
AU779941B2 (en) | 2005-02-17 |
MXPA01010588A (en) | 2004-09-06 |
HUP0200819A3 (en) | 2009-08-28 |
CA2369078A1 (en) | 2000-10-26 |
KR20020012172A (en) | 2002-02-15 |
AU4297200A (en) | 2000-11-02 |
NO20015054L (en) | 2001-12-14 |
HUP0200819A2 (en) | 2002-07-29 |
BR0009914A (en) | 2002-01-08 |
KR100718900B1 (en) | 2007-05-17 |
RU2288718C2 (en) | 2006-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL352547A1 (en) | Drugs containing inhibitors of human kinase h-sgk | |
HUP0203323A3 (en) | Tyrosine kinase inhibitors and pharmaceutical compositions containing them | |
HUP0202897A3 (en) | Diaminothiazoles and their use for inhibiting protein kinases and pharmaceutical compositions containing them | |
HUP0301005A3 (en) | Pirrolotriazine inhibitors of kinases pharmaceutical compositions containing them and their use | |
IL147217A0 (en) | New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain | |
HUP0402236A3 (en) | Heterocyclic compounds pharmaceutical compounds containing thereof and use thereof | |
IL148719A0 (en) | Kinase inhibitors as therapeutic agents | |
HUP0202682A3 (en) | Tyrosine kinase inhibitors, pharmaceutical compositions containing them and their use | |
HUP0201261A2 (en) | Indole-type derivatives as inhibitors of p38 kinase and pharmaceutical compositions containing them | |
AP2002002392A0 (en) | Indazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use | |
EG24044A (en) | pharmaceutical formulation of omeprazole | |
HUP0301269A3 (en) | Phthalazinone derivatives and pharmaceutical compositions containing them | |
HUP0104379A3 (en) | New crystalline form of omeprazole and medicament containing it | |
IL145907A0 (en) | Use of glucosylceramide synthesis inhibitors in therapy | |
EP1165084A4 (en) | Inhibitors of prenyl-protein transferases | |
IL147541A0 (en) | Oligonucleotides for inhibiting the expression of human eg5 | |
HUP0300402A3 (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them | |
AU7788500A (en) | Use of substance p antagonists for influencing the circadian timing system | |
AU2001247008A1 (en) | Variants of the human amp-activated protein kinase gamma 3 subunit | |
IL142810A0 (en) | Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles | |
GB9817348D0 (en) | Pharmaceutical use of esters | |
GB0021927D0 (en) | Use of pharmaceutical combination | |
SI1268481T1 (en) | Kinase inhibitors as therapeutic agents | |
GB9901904D0 (en) | RTherapeutic use of human pheramones | |
TW526712U (en) | Structure of case set for loading medicine |